Position in AMGN
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$37,768,753
+$1,375,501 QoQ
Shares Held
104,299
+0.8% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
2.64%
of 13F equity value
Holder Rank
#257
of 3,149 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Verity & Verity, LLC holds $179,692,626 across 7 Drug Manufacturers - General names. AMGN ranks #2 (21.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
178,972 | $45,036,514 | |
| 2 | AMGN |
Amgen Inc
This page
|
104,299 | $37,768,753 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
272,652 | $34,446,853 | |
| 4 | PFE |
Pfizer Inc
|
1,338,533 | $32,231,874 | |
| 5 | JNJ |
Johnson & Johnson
|
115,000 | $29,206,549 | |
| 6 | NVS |
Novartis AG
|
3,453 | $541,154 | |
| 7 | MRK |
Merck & Co., Inc.
|
3,587 | $460,929 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $37,768,753 | 104,299 | Shares | Other | 2026-07-28 | |
| 2026-03-31 | $36,393,252 | 103,434 | Shares | Other | 2026-04-15 | |
| 2025-12-31 | $33,088,749 | 101,093 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $28,366,179 | 100,518 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $27,105,706 | 97,080 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $29,957,713 | 96,157 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $24,106,593 | 92,490 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $28,223,984 | 87,595 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $25,735,881 | 82,368 | Shares | Sole | 2024-09-16 | |
| 2024-03-31 | $22,798,483 | 80,186 | Shares | Sole | 2024-09-16 | |
| 2023-12-31 | $25,303,997 | 87,855 | Shares | Sole | 2024-11-07 | |
| 2023-09-30 | $23,618,897 | 87,881 | Shares | Sole | 2024-11-07 | |
| 2023-06-30 | $19,255,794 | 86,730 | Shares | Sole | 2024-11-07 | |
| 2023-03-31 | $19,709,635 | 81,529 | Shares | Sole | 2024-11-07 | |
| 2022-12-31 | $19,671,210 | 74,898 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $15,977,028 | 70,883 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $16,722,495 | 68,732 | Shares | Sole | 2022-08-18 | |
| 2022-03-31 | $16,437,956 | 67,976 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $14,067,149 | 62,529 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $11,624,937 | 54,667 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $12,422,231 | 50,963 | Shares | Sole | 2021-09-20 | |
| 2021-03-31 | $12,647,261 | 50,831 | Shares | Sole | 2021-06-21 | |
| 2020-12-31 | $9,768,611 | 42,487 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $8,591,624 | 33,804 | Shares | Sole | 2020-10-06 | |
| 2020-06-30 | $7,695,168 | 32,626 | Shares | Sole | 2020-07-14 | |
| 2020-03-31 | $4,773,886 | 23,548 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||